Clinical trial
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent…
NCT00112489 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00112489 |
|---|---|
| Title | Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer |
| Official title | A Phase II Evaluation of Paclitaxel (Taxol, NSC # 673089) and Carboplatin (Paraplatin, NSC #241240) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel |
| Enrollment | 55 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2010 |
| First posted | Jun 3, 2005 |
| Last update posted | Sep 25, 2018 |
| Countries | Japan, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: